Adrian Münscher
Priv.-Doz. Dr. med.
Adrian Münscher
  • Stellvertretender Klinikdirektor
  • Oberarzt
  • Wissenschaftlicher Mitarbeiter
  • Facharzt für Hals-Nasen-Ohren-Heilkunde
Arbeitsbereich

Standort

Hauptgebäude O10 , 2. Etage, Raumnummer 02.1.100.1
Sprachen
Deutsch (Muttersprache)
Englisch

Fachgebiete

Tätigkeitsschwerpunkte

Publikationen

Zurück
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2009
  • 2008
  • 2007
  • 2006
  • 2005
  • 2004
Vor

Receptor tyrosine kinase MET as potential target of multi-kinase inhibitor and radiosensitizer sorafenib in HNSCC
Beizaei K, Gleißner L, Hoffer K, Bußmann L, Vu A, Steinmeister L, Laban S, Möckelmann N, Münscher A, Petersen C, Rothkamm K, Kriegs M
HEAD NECK-J SCI SPEC. 2019;41(1):208-215.

Tumor volume as a predictive parameter in the sequential therapy (induction chemotherapy) of head and neck squamous cell carcinomas
Bohlen M, Busch C, Sehner S, Forterre F, Bier J, Berliner C, Bußmann L, Münscher A
EUR ARCH OTO-RHINO-L. 2019 [Epub ahead of print].

Survivin expression in head and neck squamous cell carcinomas is frequent and correlates with clinical parameters and treatment outcomes
Münscher A, Prochnow S, Gulati A, Sauter G, Lörincz B, Blessmann M, Hanken H, Böttcher A, Clauditz T
CLIN ORAL INVEST. 2019;23(1):361-367.

The inflammation-reducing compatible solute ectoine does not impair the cytotoxic effect of ionizing radiation on head and neck cancer cells
Rieckmann T, Gatzemeier F, Christiansen S, Rothkamm K, Münscher A
SCI REP-UK. 2019;9(1):6594.

Therapie der rezidivierten und fernmetastasierten Plattenepithelkarzinome des Kopf-Hals-Bereichs: Highlights des ASCO-Meetings 2018
Bußmann L, Münscher A, Busch C
HNO. 2018;66(12):907-912.

Prevalence of fibroblast growth factor receptor 1 (FGFR1) amplification in squamous cell carcinomas of the head and neck
Clauditz T, Böttcher A, Hanken H, Borgmann K, Sauter G, Wilczak W, Grob T, Münscher A
J CANCER RES CLIN. 2018;144(1):53-61.

Current studies of immunotherapy in head and neck cancer
Dogan V, Rieckmann T, Münscher A, Busch C
CLIN OTOLARYNGOL. 2018;43(1):13-21.

EZH2 overexpression in head and neck cancer is related to lymph node metastasis
Nienstedt J, Schroeder C, Clauditz T, Simon R, Sauter G, Muenscher A, Blessmann M, Hanken H, Pflug C
J ORAL PATHOL MED. 2018;47(3):240-245.

Picosecond Infrared Laser (PIRL) Application in Stapes Surgery-First Experience in Human Temporal Bones
Petersen H, Gliese A, Stober Y, Maier S, Hansen N, Kruber S, Eggert D, Tóth M, Gosau T, Schlüter H, Püschel K, Schumacher U, Miller R, Münscher A, Dalchow C
OTOL NEUROTOL. 2018;39(4):e224-e230.

ERCC1, XPF and XPA-locoregional differences and prognostic value of DNA repair protein expression in patients with head and neck squamous cell carcinoma
Prochnow S, Wilczak W, Bosch V, Clauditz T, Muenscher A
CLIN ORAL INVEST. 2018 [Epub ahead of print].

A novel classification scheme for advanced laryngeal cancer midline involvement: implications for the contralateral neck
Böttcher A, Olze H, Thieme N, Stromberger C, Sander S, Münscher A, Bier J, Knopke S
J CANCER RES CLIN. 2017;143(8):1605-1612.

Induction chemotherapy followed by radiochemotherapy for locally advanced head and neck cancer as an individual treatment approach-Feasibility, safety and retrospective survival analysis in twenty-three patients
Busch C, Girke J, Tribius S, Bussmann L, Knecht R, Schafhausen P, Lörincz B, Münscher A
CLIN OTOLARYNGOL. 2017;42(6):1392-1396.

G2-checkpoint targeting and radiosensitization of HPV/p16-positive HNSCC cells through the inhibition of Chk1 and Wee1
Busch C, Kröger M, Jensen J, Kriegs M, Gatzemeier F, Petersen C, Münscher A, Rothkamm K, Rieckmann T
RADIOTHER ONCOL. 2017;122(2):260-266.

Expression of Epithelial-Mesenchymal Transition Regulating Transcription Factors in Head and Neck Squamous Cell Carcinomas
Göppel J, Möckelmann N, Münscher A, Sauter G, Schumacher U
ANTICANCER RES. 2017;37(10):5435-5440.

Survival analysis of 287 oropharyngeal squamous cell carcinoma patients in a single institution: a retrospective comparison of two consecutive time intervals with surgical and conservative treatment approaches
Münscher A, Bussmann L, Sehner S, Knaack S, Gliese A, Tribius S, Clauditz T, Lörincz B
EUR ARCH OTO-RHINO-L. 2017;274(8):3211-3219.

High-level βIII-tubulin overexpression occurs in most head and neck cancers but is unrelated to clinical outcome
Nienstedt J, Gröbe A, Clauditz T, Simon R, Muenscher A, Knecht R, Sauter G, Moebius C, Blessmann M, Heiland M, Pflug C
J ORAL PATHOL MED. 2017;46(10):986-990.

CD151 expression is frequent but unrelated to clinical outcome in head and neck cancer.
Nienstedt J, Gröbe A, Lebok P, Büscheck F, Clauditz T, Simon R, Heumann A, Sauter G, Möbius C, Münscher A, Knecht R, Blessmann M, Heiland M, Pflug C, kiehn s
CLIN ORAL INVEST. 2017;21(5):1503-1508.

Postoperative antibiotic prophylaxis in clean-contaminated head and neck oncologic surgery: a retrospective cohort study
Busch C, Knecht R, Münscher A, Matern J, Dalchow C, Lörincz B
EUR ARCH OTO-RHINO-L. 2016;273(9):2805-11.

Oncologic treatment landscape for head and neck squamous cell carcinoma: Treatment infrastructure in German-speaking countries
Kimmeyer J, Kurzweg T, Hoffmann T, Knecht R, Veit J, Möckelmann N, Münscher A, Laban S
HNO. 2016;64(7):494-500.

ERCC1 – Locoregional differences in prognostic value of ERCC1 expression in patients with head and neck squamous cell carcinoma.
Münscher A, Prochnow S, Knecht R, Wilczak W, Clauditz T
2016. -. .

Comparative study of wound healing in rat skin following incision with a novel picosecond infrared laser (PIRL) and different surgical modalities
Petersen H, Tavakoli F, Kruber S, Münscher A, Gliese A, Hansen N, Uschold S, Eggert D, Robertson W, Gosau T, Sehner S, Kwiatkowski M, Schlüter H, Schumacher U, Knecht R, Miller R
LASER SURG MED. 2016;48(4):385-91.

Immunhistochemische Analyse der Expression von ERCC1, XPF und XPA in Plattenepithelkarzinomen der Mundhöhle
Prochnow S, Münscher A, Knecht R, Clauditz T
2016. -. .

XPA – A biomarker with potential prognostic value in patients with OPSCC
Prochnow S, Münscher A, Knecht R, Wilczak W, Clauditz T
2016. -. .

XPA – A biomarker with potential prognostic value in patients with oropharyngeal head and neck squamous cell carcinoma
Prochnow S, Münscher A, Knecht R, Wilczak W, Clauditz T
2016. -. .

Survival and overall treatment time after postoperative radio(chemo)therapy in patients with head and neck cancer
Tribius S, Donner J, Pazdyka H, Münscher A, Gröbe A, Petersen C, Krüll A, Tennstedt P
HEAD NECK-J SCI SPEC. 2016;38(7):1058-1065.

PARP1 inhibition radiosensitizes HNSCC cells deficient in homologous recombination by disabling the DNA replication fork elongation response
Wurster S, Hennes F, Parplys A, Seelbach J, Mansour Khalfallah W, Zielinski A, Petersen C, Clauditz T, Münscher A, Friedl A, Borgmann K
ONCOTARGET. 2016;7(9):9732-41.

Management of sinonasal undifferentiated carcinoma with intracerebral invasion: Clinical experience at a single institution and review of the literature
Zielinski V, Laban S, Tribius S, Schafhausen P, Veldhoen S, Knecht R, Clauditz T, Muenscher A
ENT-EAR NOSE THROAT. 2016;95(1):23-8.

Reduction of thermocoagulative injury via use of a picosecond infrared laser (PIRL) in laryngeal tissues
Böttcher A, Kucher S, Knecht R, Jowett N, Krötz P, Reimer R, Schumacher U, Anders S, Münscher A, Dalchow C, Miller R
EUR ARCH OTO-RHINO-L. 2015;272(4):941-8.

Two-Year Survival Analysis of 50 Consecutive Head and Neck Cancer Patients Treated with Transoral Robotic Surgery in a Single European Centre
Lörincz B, Möckelmann N, Busch C, Münscher A, Sehner S, Dalchow C, Knecht R
ANN SURG ONCOL. 2015;22:S1028-S1033.

Timing of neck dissection in patients undergoing transoral robotic surgery for head and neck cancer
Möckelmann N, Busch C, Münscher A, Knecht R, Lörincz B
EJSO-EUR J SURG ONC. 2015.

Role of panendoscopy in identifying and managing risk of head and neck squamous cell carcinoma in routine follow-up: a retrospective clinical evaluation
Münscher A, Sehner S, Taleh J, Tribius S, Möckelmann N, Böttcher A, Gulati A, Dalchow C, Clauditz T, Knecht R
EUR ARCH OTO-RHINO-L. 2015;272(7):1769-75.

Immunhistochemische Analyse des prognostischen Wertes von ERCC1 und XPA in Patienten mit Kopf-Hals-Tumoren
Prochnow S, Münscher A, Knecht R, Wilczak W, Clauditz T
2015. -. .

Residual deficits in quality of life one year after intensity-modulated radiotherapy for patients with locally advanced head and neck cancer: Results of a prospective study
Tribius S, Raguse M, Voigt C, Münscher A, Gröbe A, Petersen C, Krüll A, Bergelt C, Singer S
STRAHLENTHER ONKOL. 2015.

Use of a microsecond Er:YAG laser in laryngeal surgery reduces collateral thermal injury in comparison to superpulsed CO2 laser
Böttcher A, Jowett N, Kucher S, Reimer R, Schumacher U, Knecht R, Wöllmer W, Münscher A, Dalchow C
EUR ARCH OTO-RHINO-L. 2014;271(5):1121-8.

Activated leukocyte cell adhesion molecule (ALCAM/CD166) expression in head and neck squamous cell carcinoma (HNSSC)
Clauditz T, von Rheinbaben K, Lebok P, Minner S, Tachezy M, Borgmann K, Knecht R, Sauter G, Wilczak W, Blessmann M, Münscher A
PATHOL RES PRACT. 2014;210(10):649-655.

Therapie von Kopf-Hals-Karzinomen
Knecht R, Busch C, Lörincz B, Schafhausen P, Tribius S, Heiland M, Jenckel F, Münscher A, Petersen C, Bokemeyer C
Hamb Ärztebl. 2014;8:12-17.

Simultaneous cytoplasmic and nuclear protein expression of melanoma antigen-A family and NY-ESO-1 cancer-testis antigens represents an independent marker for poor survival in head and neck cancer
Laban S, Atanackovic D, Luetkens T, Knecht R, Busch C, Freytag M, Spagnoli G, Ritter G, Hoffmann T, Knuth A, Sauter G, Wilczak W, Blessmann M, Borgmann K, Münscher A, Clauditz T
INT J CANCER. 2014.

ERCC 1 – Eine Expressionsanalyse in laryngealen Plattenepithelkarzinomen
Prochnow S, Knecht R, Münscher A
2014. ERCC 1 – Eine Expressionsanalyse in laryngealen Plattenepithelkarzinomen. .

A novel tool in laryngeal surgery: preliminary results of the picosecond infrared laser
Böttcher A, Clauditz T, Knecht R, Kucher S, Wöllmer W, Wilczak W, Krötz P, Jowett N, Dalchow C, Münscher A, Miller R
LARYNGOSCOPE. 2013;123(11):2770-5.

Expression of insulin-like growth factor II mRNA-binding protein 3 in squamous cell carcinomas of the head and neck
Clauditz T, Busch C, Gontarewicz A, Blessmann M, Tennstedt P, Borgmann K, Tribius S, Sauter G, Dalchow C, Knecht R, Münscher A, Wilczak W
J ORAL PATHOL MED. 2013;42(2):125-32.

Abundant expression of mTOR kinase in salivary gland tumors - potentials as therapy target?
Clauditz T, Gontarewicz A, Bokemeyer C, Sauter G, Knecht R, Münscher A, Wilczak W
J ORAL PATHOL MED. 2013;42(10):769-73.

Investigation of noise levels generated by otologic drills
Dalchow C, Hagemeier K, Münscher A, Knecht R, Kameier F
EUR ARCH OTO-RHINO-L. 2013;270(2):505-510.

Radiographic examination of patients with dehiscence of semicircular canals with digital volume tomography
Dalchow C, Knecht R, Grzyska U, Münscher A
EUR ARCH OTO-RHINO-L. 2013;270(2):511-9.

Therapie der Rezidiv- und Fernmetastasen bei Plattenepithelkarzinomen des Kopf- und Halsbereichs: Highlights des ASCO-Meetings 2013
Hezel M, Kurzweg T, Münscher A, Schafhausen P, Knecht R
HNO. 2013;61(11):911-3.

Laryngeal dislocation after ventral fusion of the cervical spine
Krauel J, Winkler D, Münscher A, Tank S
Indian journal of anaesthesia. 2013;57(3):285-8.

Molecular targeting agents in the context of primary chemoradiation strategies.
Laban S, Busch C, Münscher A, Tribius S, Schafhausen P, Knecht R
HEAD NECK-J SCI SPEC. 2013;35(5):738-746.

Die wichtigsten Studienergebnisse der primären Radio-Chemo-Therapie von Kopf-Hals-Tumoren: Highlights des ASCO-Meetings 2013
Münscher A, Busch C, Schafhausen P, Tribius S, Knecht R
HNO. 2013;61(11):905-10.

Measurement and comparison of labyrinthine structures with the digital volume tomography: ancient Egyptian mummies' versus today's temporal bones.
Schmidt C, Harbort J, Knecht R, Grzyska U, Münscher A, Dalchow C
EUR ARCH OTO-RHINO-L. 2013;270(3):831-840.

Xerostomia after radiotherapy. What matters--mean total dose or dose to each parotid gland?
Tribius S, Sommer J, Prosch C, Bajrovic A, Münscher A, Blessmann M, Krüll A, Petersen C, Todorovic M, Tennstedt P
STRAHLENTHER ONKOL. 2013;189(3):216-222.

Epidermal growth factor receptor (EGFR) in salivary gland carcinomas: potentials as therapeutic target
Clauditz T, Gontarewicz A, Lebok P, Tsourlakis M, Grob T, Münscher A, Sauter G, Bokemeyer C, Knecht R, Wilczak W
ORAL ONCOL. 2012;48(10):991-6.

Epidermal growth factor receptor (EGFR) in salivary gland carcinomas: potentials as therapeutic target.
Clauditz T, Gontarewicz A, Lebok P, Tsourlakis M, Grob T, Münscher A, Sauter G, Bokemeyer C, Knecht R, Wilczak W
ORAL ONCOL. 2012;48(10):991-996.

11q21 rearrangement is a frequent and highly specific genetic alteration in mucoepidermoid carcinoma
Clauditz T, Gontarewicz A, Wang C, Münscher A, Laban S, Tsourlakis M, Knecht R, Sauter G, Wilczak W
DIAGN MOL PATHOL. 2012;21(3):134-137.

Imaging of ancient Egyptian mummies' temporal bones with digital volume tomography.
Dalchow C, Schmidt C, Harbort J, Knecht R, Grzyska U, Münscher A
EUR ARCH OTO-RHINO-L. 2012;269(10):2277-2284.

Neue Aspekte HPV-positiver Kopf-Hals-Karzinome. Highlights vom ASCO-Kongress 2011
Kofler B, Uecker F, Muenscher A, Knecht R
HNO. 2012;60(5):404-7.

[New aspects of HPV-positive head and neck cancer. Highlights from the 2011 ASCO Congress].
Kofler B, Uecker F, Münscher A, Knecht R
HNO. 2012;60(5):404-407.

Neue Aspekte der primären Radiochemotherapie bei Kopf-Hals-Tumoren. Highlights vom ASCO-Kongress 2011
Laban S, Wang C, Knecht R, Tribius S, Münscher A
HNO. 2012;60(5):393-7.

[New aspects of primary radiochemotherapy in head and neck cancer : Highlights from the 2011 ASCO Congress].
Laban S, Wang C, Knecht R, Tribius S, Münscher A
HNO. 2012;60(5):393-397.

Die wichtigsten Studienergebnisse der primären Radiochemotherapie von Kopf-Hals-Tumoren: Highlights vom ASCO-Meeting 2012
Laban S, Zielinski V, Busch C, Münscher A, Schafhausen P, Tribius S, Knecht R
HNO. 2012;60(11):962-7.

[The most important results on primary chemoradiation for head and neck squamous cell carcinoma: highlights from the 2012 ASCO meeting].
Laban S, Zielinski V, Busch C, Münscher A, Schafhausen P, Tribius S, Knecht R
HNO. 2012;60(11):962-967.

Neue Aspekte zur aktuellen Therapie von Oropharynxkarzinomen: Highlights vom ASCO-Kongress 2012
Loewenthal M, Vitez E, Laban S, Münscher A, Güldenzoph B, Knecht R, Busch C
HNO. 2012;60(11):951-6.

[New aspects of current therapeutic strategies in oropharyngeal carcinoma: highlights of the 2012 ASCO meeting].
Löwenthal M, Vitez E, Laban S, Münscher A, Güldenzoph B, Knecht R, Busch C
HNO. 2012;60(11):951-956.

Neue Therapieaspekte bei Rezidiv und Fernmetastase des Kopf- und Hals-Karzinoms: Highlights vom ASCO-Kongress 2012
Schöpper S, Laban S, Güldenzoph B, Münscher A, Knecht R, Kurzweg T
HNO. 2012;60(11):957-61.

[New aspects in the therapy of recurrence and metastasis of head and neck cancer: highlights from the 2012 ASCO meeting].
Schöpper S, Laban S, Güldenzoph B, Münscher A, Knecht R, Kurzweg T
HNO. 2012;60(11):957-961.

Human epidermal growth factor receptor 2 (HER2) in salivary gland carcinomas.
Clauditz T, Reiff M, Gravert L, Gnoss A, Tsourlakis M, Münscher A, Sauter G, Bokemeyer C, Knecht R, Wilczak W
PATHOLOGY. 2011;43(5):459-464.

Globusgefühl und Hustenreiz durch eine gestielte Raumforderung im Bereich des Waldeyer’schen Rachenrings
Laban S, Münscher A, Habermann C, Quaas A, Knecht R
GMS Curr Posters Otorhinolaryngol Head Neck Surg. 2011;7:42.

The endoscopic approach to the neck: a review of the literature, and overview of the various techniques
Münscher A, Dalchow C, Kutta H, Knecht R
SURG ENDOSC. 2011;25(5):1358-63.

The endoscopic approach to the neck: a review of the literature, and overview of the various techniques.
Münscher A, Dalchow C, Kutta H, Knecht R
SURG ENDOSC. 2011;25(5):1358-1363.

[Fluorescein aspiration during induction of anaesthesia : complication preceding surgical treatment of cerebrospinal fluid fistula].
Olotu C, Münscher A, Schmidt G
ANAESTHESIST. 2011;60(8):740-742.

Fluoreszeinaspiration während der Narkoseeinleitung: Komplikation vor operativer Sanierung einer Liqourfistel
Olotu C, Münscher A, Schmidt G
ANAESTHESIST. 2011;60(8):740-2.

Complete activation of thyroid hormone receptor β by T3 is essential for normal cochlear function and morphology in mice.
Richter C, Münscher A, Machado D, Wondisford F, Ortiga-Carvalho T
CELL PHYSIOL BIOCHEM. 2011;28(5):997-1008.

Benign and malignant salivary gland diseases in children A retrospective study of 549 cases from the Salivary Gland Registry, Hamburg.
Münscher A, Diegel T, Jaehne M, Ussmüller J, Koops S, Sanchez-Hanke M
AURIS NASUS LARYNX. 2009;36(3):326-331.

Integration of human papilloma virus type 26 in laryngeal cancer of a child.
Münscher A, Feucht H, Kutta H, Tesche S, Wenzel S
AURIS NASUS LARYNX. 2009;36(2):232-234.

[Laryngeal squamous cell carcinoma in a 12-year-old boy]
Münscher A, Feucht H, Kutta H, Tesche S, Wenzel S
HNO. 2009;57(6):617-620.

Plattenepithelkarzinom des Larynx bei einem 12-jährigen Jungen
Münscher A, Feucht H, Kutta H, Tesche S, Wenzel S, Münscher A
HNO. 2009;57(6):617-20.

[Painless cervical mass in an adolescent]
Kutta H, Schäfer H, Münscher A, Wenzel S
HNO. 2008;56(8):813-816.

Schmerzlose zervikale Raumforderung eines Jugendlichen
Kutta H, Schäfer H, Münscher A, Wenzel S
HNO. 2008;56(8):813-6.

Endocochlear potential depends on Cl- channels: mechanism underlying deafness in Bartter syndrome IV
Rickheit G, Maier H, Strenzke N, Andreescu C, De Zeeuw C, Muenscher A, Zdebik A, Jentsch T
EMBO J. 2008;27(21):2907-17.

Endocochlear potential depends on Cl- channels: mechanism underlying deafness in Bartter syndrome IV.
Rickheit G, Maier H, Strenzke N, Andreescu C, Zeeuw D, Münscher A, Muenscher A, Zdebik A, Jentsch T
EMBO J. 2008;27(21):2907-2917.

Leukoencephalopathy upon disruption of the chloride channel ClC-2.
Blanz J, Schweizer M, Auberson M, Maier H, Münscher A, Hübner C, Jentsch T
J NEUROSCI. 2007;27(24):6581-6589.

Die Wegener Granulomatose: Klinik, Diagnose und Therapie anhand eines Fallberichts und einer Literaturübersicht
Tesche S, Münscher A, Metternich F
LARYNGORHINOOTOLOGIE. 2007;86(11):775-9.

[Wegener's granulomatosis in ENT: clinical presentation, diagnosis and therapy]
Tesche S, Münscher A, Metternich F
LARYNGORHINOOTOLOGIE. 2007;86(11):775-779.

Antimicrobial defence mechanisms of the human parotid duct.
Kutta H, May J, Jaehne M, Münscher A, Paulsen F
J ANAT. 2006;208(5):609-619.

[Human insulin vs. analogs. What is the cost of supplementary insulin therapy?]
Lundershausen R, Potthoff F, Häuser C, Kaiser M, Münscher A
MMW Fortschr Med. 2006;148(45):42.

[Primary involvement of the eye without the typical sinus symptoms]
Münscher A, Tesche S, Kutta H, Grundmann T
HNO. 2006;54(6):468-471.

[Assessment of motivational changes in tinnitus sufferers. A study of the transtheoretical model]
Härter M, Battlehner J, Münscher A, Graul J, Maurischat C
HNO. 2005;53(8):707-710, 712-715.

[Deafness with tinnitus]
Münscher A, Grzyska U, Leuwer R
HNO. 2004;52(7):616-619.

Schwerhörigkeit mit Tinnitus
Münscher A, Grzyska U, Leuwer R
HNO. 2004;52(7):616-9.

Der interessante Fall Nr. 63
Münscher A, Lessle M, Grundmann T
LARYNGORHINOOTOLOGIE. 2004;83(9):617-9.

[The monthly interesting case - case no. 63]
Münscher A, Lessle M, Grundmann T
LARYNGORHINOOTOLOGIE. 2004;83(9):617-619.

Letzte Aktualisierung aus dem FIS: 24.06.2019 - 00:35 Uhr